Atricure (ATRC) Stock Forecast & Price Target

Compare

376 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ATRC Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Atricure

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ATRC Stock 12 Month Forecast

Average Price Target

$49.75

▲(32.10% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Atricure in the last 3 months. The average price target is $49.75 with a high forecast of $60.00 and a low forecast of $38.00. The average price target represents a 32.10% change from the last price of $37.66.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","61":"$61","30.25":"$30.3","40.5":"$40.5","50.75":"$50.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$49.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$38.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,30.25,40.5,50.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.41,36.378461538461536,38.346923076923076,40.315384615384616,42.28384615384615,44.25230769230769,46.22076923076923,48.18923076923077,50.15769230769231,52.12615384615384,54.09461538461538,56.06307692307692,58.03153846153846,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.41,35.589999999999996,36.769999999999996,37.949999999999996,39.129999999999995,40.309999999999995,41.489999999999995,42.67,43.849999999999994,45.03,46.209999999999994,47.39,48.57,{"y":49.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.41,34.68615384615384,34.96230769230769,35.238461538461536,35.51461538461538,35.79076923076923,36.066923076923075,36.34307692307692,36.61923076923077,36.895384615384614,37.17153846153846,37.44769230769231,37.723846153846154,{"y":38,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.5,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.04,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.8,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.51,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.06,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.56,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.87,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.74,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$60.00

Average Price Target$49.75

Lowest Price Target$38.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jack Scalprey

TR | OpenAI - 4o

$39→$38

Hold

0.90%

Upside

Downgraded

08/22/25

AI Generated ArticleAI Generated Article

William Plovanic

Canaccord Genuity

$53

Buy

40.73%

Upside

Reiterated

08/13/25

AtriCure's Strategic Growth and Investment Initiatives Drive Buy Rating Amid Market Challenges

Daniel Stauder

Citizens JMP

$60

Buy

59.32%

Upside

Reiterated

07/30/25

Citizens JMP Sticks to Its Buy Rating for Atricure (ATRC)We reiterate our Market Outperform rating and $60 price target on AtriCure following the companys full 2Q25 results, which reflected top- and bottom-line beats to Street expectations as well as corresponding guidance raises.

Danielle Antalffy

UBS

$58

Buy

54.01%

Upside

Reiterated

07/30/25

UBS Sticks to Their Buy Rating for Atricure (ATRC)

Rick Wise

Stifel Nicolaus

$48

Buy

27.46%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Their Buy Rating for Atricure (ATRC)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$46→$42

Buy

11.52%

Upside

Reiterated

07/30/25

J.P. Morgan Remains a Buy on Atricure (ATRC)

Marie Thibault

BTIG

$52→$54

Buy

43.39%

Upside

Reiterated

07/30/25

AtriCure price target raised to $54 from $52 at BTIGAtriCure price target raised to $54 from $52 at BTIG

Michael Matson

Needham

$45

Buy

19.49%

Upside

Reiterated

07/30/25

Atricure's Strong Financial Performance and Growth Prospects Justify Buy Rating

Suraj Kalia

Oppenheimer

$45→$40

Buy

6.21%

Upside

Reiterated

04/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: The Ensign Group (NASDAQ: ENSG), Verona Pharma (NASDAQ: VRNA) and Atricure (NASDAQ: ATRC)

Matthew O'Brien

Piper Sandler

$50

Buy

32.77%

Upside

Reiterated

04/30/25

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jack Scalprey

TR | OpenAI - 4o

$39→$38

Hold

0.90%

Upside

Downgraded

08/22/25

AI Generated ArticleAI Generated Article

William Plovanic

Canaccord Genuity

$53

Buy

40.73%

Upside

Reiterated

08/13/25

AtriCure's Strategic Growth and Investment Initiatives Drive Buy Rating Amid Market Challenges

Daniel Stauder

Citizens JMP

$60

Buy

59.32%

Upside

Reiterated

07/30/25

Danielle Antalffy

UBS

$58

Buy

54.01%

Upside

Reiterated

07/30/25

UBS Sticks to Their Buy Rating for Atricure (ATRC)

Rick Wise

Stifel Nicolaus

$48

Buy

27.46%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Their Buy Rating for Atricure (ATRC)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$46→$42

Buy

11.52%

Upside

Reiterated

07/30/25

J.P. Morgan Remains a Buy on Atricure (ATRC)

Marie Thibault

BTIG

$52→$54

Buy

43.39%

Upside

Reiterated

07/30/25

AtriCure price target raised to $54 from $52 at BTIGAtriCure price target raised to $54 from $52 at BTIG

Michael Matson

Needham

$45

Buy

19.49%

Upside

Reiterated

07/30/25

Atricure's Strong Financial Performance and Growth Prospects Justify Buy Rating

Suraj Kalia

Oppenheimer

$45→$40

Buy

6.21%

Upside

Reiterated

04/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: The Ensign Group (NASDAQ: ENSG), Verona Pharma (NASDAQ: VRNA) and Atricure (NASDAQ: ATRC)

Matthew O'Brien

Piper Sandler

$50

Buy

32.77%

Upside

Reiterated

04/30/25

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Atricure

1 Month

xxx

Success Rate

15/23 ratings generated profit

Average Return

+4.21%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 65.22% of your transactions generating a profit, with an average return of +4.21% per trade.

3 Months

xxx

Success Rate

15/23 ratings generated profit

Average Return

+11.18%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +11.18% per trade.

1 Year

Suraj KaliaOppenheimer

Success Rate

20/23 ratings generated profit

Average Return

+39.56%

reiterated a buy rating 4 months ago

Copying Suraj Kalia's trades and holding each position for 1 Year would result in 86.96% of your transactions generating a profit, with an average return of +39.56% per trade.

2 Years

xxx

Success Rate

22/23 ratings generated profit

Average Return

+55.03%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +55.03% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATRC Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ATRC has received 10 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. ATRC average Analyst price target in the past 3 months is 49.75.

Each month's total comprises the sum of three months' worth of ratings.

ATRC Financial Forecast

ATRC Earnings Forecast

Next quarter’s earnings estimate for ATRC is -$0.11 with a range of -$0.14 to -$0.09. The previous quarter’s EPS was -$0.13. ATRC beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.04% of the time in the same period. In the last calendar year ATRC has Outperformed its overall industry.

ATRC Sales Forecast

Next quarter’s sales forecast for ATRC is $131.25M with a range of $130.20M to $133.00M. The previous quarter’s sales results were $136.14M. ATRC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.27% of the time in the same period. In the last calendar year ATRC has Outperformed its overall industry.

ATRC Stock Forecast FAQ

What is ATRC’s average 12-month price target, according to analysts?

Based on analyst ratings, Atricure’s 12-month average price target is 49.75.

What is ATRC’s upside potential, based on the analysts’ average price target?

Atricure has 32.10% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ATRC a Buy, Sell or Hold?

Atricure has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Atricure’s price target?

The average price target for Atricure is 49.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.00 ,the lowest forecast is $38.00. The average price target represents 32.10% Increase from the current price of $37.66.

What do analysts say about Atricure?

Atricure’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of ATRC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Atricure (ATRC) Stock Forecast & Price Target

ATRC Analyst Ratings

ATRC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Atricure

ATRC Analyst Recommendation Trends

ATRC Financial Forecast

ATRC Earnings Forecast

ATRC Sales Forecast

ATRC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts